NEW YORK, NY--(Marketwire -02/09/12)- GreenCell, Inc. (OTC.BB: GCLL.OB - News) announced they have developed an automated pelletizer that provides complete chemical inertness while in production. The unit will be used for producing UltraTemp-C devices.
SenCer Inc., GreenCell's joint venture partner, has developed a ceramic composite material called UltraTemp™ based upon ceramic fiber/ceramic matrix combinations. Several blends have been developed with high purity oxide and carbide chemistries. These materials have exhibited excellent thermal and temperature stability as high as 1800°C. The physical pore structure and fiber physiology have allowed an unprecedented bond when coatings of high purity oxide and metals are placed on the surface and co-fired with the composite.
The high temperature stability would make products developed with UltraTemp a perfect fit for fuel cells, medical equipment, automotive applications as well as commercial and household appliances.
Other active stocks are Allezoe Medical (OTCQB: ALZM.OB - News) Lifevantage Corp (OTCQB: LFVN.OB - News) and Advanced Cell Tech (OTCQB: ACTC.OB - News).
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.
